The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...
Eli Lilly has stepped into the gene therapy space after announcing a deal to acquire Prevail Therapeutics, a company focused on developing adeno-associated virus (AAV)-based gene therapies for ...
Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...
A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...
These are the conversations taking centre stage at the MAD World Summit 2026, the UK’s leading event dedicated to workplace ...
Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...
How do we translate individual experiences into support that helps others and create support that feels personal but remains ...
Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results